Tag: Marc N. Casper
Thermo Fisher announces $3.1bn acquisition of proteomics leader Olink
In a transformative move within the life sciences domain, Thermo Fisher Scientific Inc. is set to acquire proteomics pioneer Olink Holding AB for a compelling ... Read More
Thermo Fisher Scientific closes $2.8bn acquisition of Binding Site
Thermo Fisher Scientific, an American analytical laboratory instrument manufacturing company, has closed the previously announced acquisition of The Binding Site Group, a UK- based diagnostic ... Read More
Thermo Fisher to buy specialist protein diagnostics company Binding Site
Thermo Fisher Scientific has agreed to acquire The Binding Site Group, a UK-based specialist protein diagnostics company, for £2.25 billion ($2.6 billion) in an all-cash ... Read More
Thermo Fisher to acquire clinical research services provider PPD for $21bn
Thermo Fisher Scientific has agreed to acquire PPD, a US-based clinical research services provider, for $47.50 per share or $20.9 billion. The consideration includes assumption ... Read More
Thermo Fisher scraps $11.5bn Qiagen deal after failed tender offer
Thermo Fisher Scientific has scrapped its previously planned $11.5 billion acquisition of Qiagen after its offer to buy all of the ordinary shares of the ... Read More
Thermo Fisher, WuXi, Mayo Clinic to develop total antibodies Covid-19 test
US life sciences company Thermo Fisher Scientific said that it will collaborate with China-based WuXi Diagnostics and Mayo Clinic to develop a total antibodies Covid-19 ... Read More
Thermo Fisher to acquire Qiagen to expand specialty diagnostics portfolio
Thermo Fisher acquisition of Qiagen : US life sciences company Thermo Fisher Scientific has agreed to acquire Qiagen, a Netherlands-based provider of molecular diagnostics and ... Read More
Thermo Fisher coronavirus diagnostic test gets FDA’s emergency use order
Thermo Fisher Scientific has been granted an emergency use authorization (EUA) for its coronavirus diagnostic test from the US Food and Drug Administration (FDA). The ... Read More
Thermo Fisher to acquire viral vector CDMO Brammer Bio for $1.7bn
Global life sciences company Thermo Fisher Scientific has agreed to acquire Massachusetts-based Brammer Bio from Ampersand Capital Partners for about $1.7 billion in cash. Brammer ... Read More